PTHLH and breast carcinoma: Moreover, reversal of the dominant-negative signaling blockade by overexpressing a constitutively active TβR-I receptor in these breast cancer cells increased production of parathyroid hormone-related protein (PTHrP) by the tumor cells and enhanced their osteolytic bone metastases.